The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 37,860 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 83,249 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 68,285 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 84,145 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
| ALLERGAN PLC | SHS | G0177J108 | 168,290 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 50,705 | 4,390,000 | SH | SOLE | 4,390,000 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 62,608 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 41,654 | 2,950,000 | SH | SOLE | 2,950,000 | 0 | 0 | ||
| AVROBIO INC | COM | 05455M100 | 7,060 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 81,487 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO | COM | 110122108 | 76,065 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| BROOKDALE SENIOR LIVING | COM | 112463104 | 94,750 | 12,500,000 | SH | SOLE | 12,500,000 | 0 | 0 | ||
| CYCLERION THERAPEUTICS INC | COM | 23255M105 | 26,992 | 2,227,052 | SH | SOLE | 2,227,052 | 0 | 0 | ||
| DAVITA INC | COM | 23918K108 | 85,605 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 21,340 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| GLYCOMIMETICS INC | COM | 38000Q102 | 15,085 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| HCA HEALTHCARE INC | COM | 40412C101 | 72,252 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 45,360 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| MYLAN N V | SHS EURO | N59465109 | 59,340 | 3,000,000 | SH | Call | SOLE | 3,000,000 | 0 | 0 | |
| MYLAN N V | SHS EURO | N59465109 | 168,130 | 8,500,000 | SH | SOLE | 8,500,000 | 0 | 0 | ||
| MYRIAD GENETICS INC | COM | 62855J104 | 28,630 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 54,645 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| NOVO-NORDISK A S | ADR | 670100205 | 36,190 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| PERRIGO CO PLC | SHS | G97822103 | 95,013 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 56,490 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| SURGERY PARTNERS INC | COM | 86881A100 | 1,182 | 160,084 | SH | SOLE | 160,084 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 5,454 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| SYNTHORX INC | COM | 87167A103 | 30,297 | 1,862,116 | SH | SOLE | 1,862,116 | 0 | 0 | ||
| TENET HEALTHCARE CORP | COM NEW | 88033G407 | 69,678 | 3,150,000 | SH | SOLE | 3,150,000 | 0 | 0 | ||
| TRANSLATE BIO INC | COM | 89374L104 | 14,865 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 31,900 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 74,375 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| WRIGHT MED GROUP N V | ORD SHS | N96617118 | 15,473 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| ZYMEWORKS INC | COM | 98985W102 | 37,200 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||